Request for Information: FDA IT Infrastructure Services
Closed Pre-Solicitation Posted
- Solicitation number
- FDA-RFI-75F40126Q00262
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- Not on record
- Place of performance
- Silver Spring, Maryland 20903, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration is conducting market research through a Request for Information on IT Infrastructure Services, with responses due by July 3, 2026. This is a pre-solicitation market survey only and does not commit the government to award a contract.
The FDA seeks industry feedback on a proposed three-tiered hybrid pricing model for anticipated contractual support: Firm-Fixed-Price for baseline operations, Variable Firm-Fixed-Price for fluctuating operational volume, and Billable Hours for non-business-as-usual projects. Respondents should address the effectiveness of this pricing approach, boundary definitions between pricing tiers to prevent scope creep, mapping of End-of-Life hardware management activities across pricing categories, transition-in pricing best practices using Time and Materials compensation, and contractor capability to assume and manage the FDA's existing 5,300-square-foot colocation lease in Ashburn, Virginia.
Place of performance includes the Ashburn, Virginia colocation facility. Responses are limited to three pages and must include company name, mailing address, point of contact information, UEI, socio-economic status, and GSA contract number. No set-aside is anticipated.
The government assumes no financial responsibility for response costs. Respondents will not receive acknowledgment of receipt, notification of outcomes, individualized feedback, or meetings with the FDA. The government reserves the right to use non-proprietary technical information in any resultant solicitation. Proprietary, classified, confidential, or sensitive information should not be included in responses. Direct responses to Michelle Dacanay at michelle.dacanay@fda.hhs.gov.
Notice text
The U.S. Food and Drug Administration (FDA) is issuing this Request for Information (RFI) as a means of conducting market research, pursuant to FAR Part 10 Market Research.
This is a REQUEST FOR INFORMATION (RFI) ONLY, not a Request for Quote (RFQ) and does not commit the Government to award a contract now or in the future.
The purpose of this RFI is to obtain information from industry based on the questions contained in this notice. Submission of any information in response to this market survey is purely voluntary and FDA welcomes responses from all interested parties; the Government assumes no financial responsibility for any costs incurred.
The FDA will use the results of the market research to determine if sources are capable of satisfying the agency's requirements exist based on the response received to the Government’s questions contained in this notice. The FDA does not intend to make a selection decision or award a contract on the basis of responses. Acknowledgement of receipt of responses will not be made, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold meetings concerning this RFI with any interested parties. However, FDA reserves the right to contact vendors if additional information is required.
Respondents will not receive individualized feedback on any suggestions or questions submitted. No basis for claims against the United States government shall arise as a result of a response to this request for information or from the United States government's use of such information. Proprietary, classified, confidential, or sensitive information should not be included in your response. The Federal Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
While the Government anticipates establishing a contract for the FDA IT Infrastructure Services which requires contractual support, A SOLICITATION IS NOT CURRENTLY AVAILABLE. The Government is not obligated and will not pay for any information received from potential sources as a result of this sources sought.
Email to: Michelle Dacanay, michelle.dacanay@fda.hhs.gov by the posted due date and time.
No phone calls will be accepted for this notice
See attachment for complete RFI information.
Files
| File | Type | Posted |
|---|---|---|
| RFI (FDA-RFI-75F40126Q00262) FDA IT Infrastructure Services.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Comprehensive Data Management & Streamlining Solution for Business-Critical Data (Data Stream) | Food and Drug Administration | Woman-Owned Small Business | |
| Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ | FDA Office of Acquisition and Grant Services | Service-Disabled Veteran-Owned Small Business | |
| RFI pharmacy temperature monitoring | Immigration and Customs Enforcement | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity